5 Best NASDAQ Stocks Under $5 to Buy Right Now

3. Rocket Pharmaceuticals Inc. (NASDAQ:RCKT)

Number of Hedge Fund Holders: 39

Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the best NASDAQ stocks under $5 to buy right now. On May 7, Rocket Pharmaceuticals reported a Q1 2026 net loss of $47.6 million ($0.42 per share). Driven by a recent realignment and lower headcount, R&D expenses fell to $31.5 million, and G&A expenses dropped to $17.1 million. The company held $144.4 million in cash at quarter-end, which jumps to $322.6 million on a pro forma basis following the $180 million sale of its Priority Review Voucher, extending its operational runway into Q2 2028.

The financial runway was boosted by the FDA’s accelerated approval of KRESLADI for pediatric patients with severe leukocyte adhesion deficiency-I (LAD-I). This regulatory milestone granted Rocket a Rare Pediatric Disease Priority Review Voucher, which the company subsequently monetized for $180 million in non-dilutive proceeds.

In its clinical pipeline, Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) reinitiated dosing in the pivotal Phase 2 trial of RP-A501 for Danon disease under a modified protocol, with a program update targeted for the second half of 2026. The company is also aligning with the FDA on a Phase 2 trial design for RP-A601 in arrhythmogenic cardiomyopathy, and expects first-patient dosing for its Phase 1 BAG3-dilated cardiomyopathy study in mid-2026.

Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is a biotechnology company focused on genetic therapies for rare disorders. Its pipeline includes lentiviral and AAV-based programs targeting immunologic and cardiovascular diseases.